Patent · US Expired

2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists

US4684646A · kind A · utility

18Cited by
9References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 1985
Grant dateAug 4, 1987
Priority date—
Expiry dateNov 18, 2005

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method of antagonizing the function of cholecystokinins in a disease state in mammals, especially in humans, which comprises administering a pharmaceutically-effective amount of certain 2-acylaminomethyl-1,4-benzodiazepine derivatives or their salts, alone or with a pharmaceutical carrier, with or without an adjuvant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.